ACRV
ACRV
Positions held
Your positionsACRV isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-15 · What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock
2026-09-03 · Acrivon Therapeutics, Inc. (ACRV) Just Flashed Golden Cross Signal: Do You Buy?
2026-09-02 · Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
2026-08-31 · Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
2026-08-24 · Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy
2026-08-12 · Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
Price (daily)
Full chart · RSI · MACD · patterns